SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-463557
Filing Date
2013-12-05
Accepted
2013-12-05 16:16:51
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d621231d10q.htm 10-Q 564032
2 EX-31.1 d621231dex311.htm EX-31.1 9423
3 EX-31.2 d621231dex312.htm EX-31.2 9387
4 EX-32.1 d621231dex321.htm EX-32.1 4340
5 EX-32.2 d621231dex322.htm EX-32.2 4247
  Complete submission text file 0001193125-13-463557.txt   3266685

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aeri-20130930.xml EX-101.INS 356224
7 XBRL TAXONOMY EXTENSION SCHEMA aeri-20130930.xsd EX-101.SCH 36892
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aeri-20130930_cal.xml EX-101.CAL 41525
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aeri-20130930_def.xml EX-101.DEF 124151
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aeri-20130930_lab.xml EX-101.LAB 278292
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aeri-20130930_pre.xml EX-101.PRE 201650
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 131260076
SIC: 2836 Biological Products, (No Diagnostic Substances)